2m 2m 2m 2m 2m 2m 2m
AN2 THERAPEUTIC (ANTX)
NASDAQ
$4.47+$0.13 (+3.12%)
Price as of Nov 11, 2026 7:55 PM EST- $163.4MMarket Cap
- 260.83%1-Year Change
- BiotechnologyIndustry
AN2 THERAPEUTIC (ANTX)
$4.47+$0.13 (+3.12%)
ANTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.33 | ||
Change | +$0.33 (+8.25%) | ||
Open | $3.99 | ||
High | $4.50 | ||
Low | $3.93 | ||
Previous Close | $4.00 | ||
Volume | 271,603 | ||
30-Day Average Volume | 284,082 | ||
1-Week Change | 3.59% | ||
1-Month Change | -1.59% | ||
1-Year Change | 260.83% | ||
3-Year Change | -69.74% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.7M | ||
Total Assets | $82.0M | ||
Market Cap | $163.4M | ||
Enterprise Value | $143.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.0M | ||
Free Cash Flow | -$6.1M | ||
EBIT | -$8.0M | ||
EBITDA | -$8.0M | ||
Net Working Capital | $59.5M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -25 | ||
PEG | -5 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 04/12/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue